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The homeobox gene Hb9 is expressed selectively by motor neurons (MNs) in the developing CNS. Previous studies have identified a
9-kb 5V fragment of the mouse Hb9 gene that is sufficient to direct gene expression to spinal MNs in vivo. Here, we sought to identify
more discrete MN-specifying elements, using homology searches between genomic sequences of evolutionarily distant species. Based on
homology screening of the mouse and human Hb9 promoters, we identified a 3.6-kb Hb9 enhancer that proved sufficient to drive MN-
specific lacZ expression. We then compared mouse, human, and pufferfish (Fugu rubripes) genomic sequences, and identified a
conserved 438-bp sequence, consisting of noncontiguous 313-bp and 125-bp fragments, residing within the 3.6-kb Hb9 enhancer. The
zebrafish (Danio rerio) Hb9 genomic region was then found to have two identical copies of the 125-bp sequence, but no counterpart for
the 313-bp sequence. Transgenic analysis showed that the 125-bp alone was both necessary and sufficient to direct spinal MN-specific
lacZ expression, whereas the 313-bp sequence had no such enhancer activity. Moreover, the 125-bp Hb9 enhancer was found to harbor
two Hox/Pbx consensus-binding sequences, mutations of which completely disrupted thoracolumbar Hb9 expression. These data suggest
that Hox/Pbx plays a critical role in the segmental specification of spinal MNs. Together, these results indicate that the molecular
pathways regulating Hb9 expression are evolutionarily conserved, and that MN-specific gene expression may be directed and achieved
using a small 125-bp 5V enhancer.
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In the vertebrate CNS, the specification of neural identity
is initiated by humoral inductive factors, that impose a
specific profile of transcription factor expression on neural
progenitor cells, thereby restricting their phenotypic differ-
entiation (Goridis and Brunet, 1999; Jessell and Melton,
1992). In the developing spinal neuroepithelium, motor0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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(S.A. Goldman).neuron (MN) progenitors arise in part in response to the
ventralizing action of Sonic hedgehog (Shh) (Briscoe and
Ericson, 2001). The specification of MN progenitors by Shh
is mediated through the patterned expression of homeodo-
main (HD) and basic helix–loop–helix (bHLH) transcrip-
tion factors; these function primarily as transcriptional
repressors (Muhr et al., 2001), whose cross-regulatory
interactions establish distinct progenitor domains (Briscoe
et al., 1999, 2000; Jessell, 2000; Vallstedt et al., 2001).
Through this general scheme, MN progenitors are restricted
to a narrow region of the ventral neural tube termed the
pMN domain (Briscoe et al., 2000; Jessell, 2000; Pierani et
al., 2001). Within this domain, two HD proteins, Nkx6.1 and
Pax6, and a bHLH protein, Olig2, characterize MN83 (2005) 474 – 485
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expression of distinct MN transcription factors, which
include the HD protein HB9.
HB9 is expressed selectively by post-mitotic spinal MNs
in the developing vertebrate CNS, and serves as a marker for
the MN phenotype (Arber et al., 1999; Tanabe et al., 1998).
Genetic studies in mice have suggested its importance in the
consolidation and maintenance of MN identity (Arber et al.,
1999; Thaler et al., 1999). A 5V 9-kb Hb9 promoter has been
shown to drive MN-specific expression in vivo (Arber et al.,
1999; Wichterle et al., 2002). Nonetheless, the regulatory
control of Hb9 gene expression is only poorly understood. In
this study, we sought to identify cis-acting regulatory
elements of the Hb9 gene specifically active in MNs, so as
to predict factors that might regulate MN induction. Using
cross-species homology analysis with enhancer screening by
transgenesis, we identified a highly conserved 125-bp cis-
acting regulatory sequence, which appears to direct gene
expression to spinal MNs. Moreover, by site-directed muta-
genesis, we found that disrupting Hox/Pbx binding sites
within this 125-bpHb9 enhancer completely abolished b-gal
expression in the thoracic and lumber spinal cord, without
affecting the reporter gene expression in the cervical levels of
the cord. Thus, the 5V 9-kb Hb9 promoter harbors a highly
conserved 125-bp element that directs vertebrate MN gene
expression, and Hox/Pbx binding sites within this element
appear necessary for thoracolumbar MN specification.Materials and methods
Homology screening
A 9-kb 5V non-coding fragment of the mouse Hb9 gene
(a kind gift from Dr. Thomas Jessell) was sequenced. The
corresponding human genome sequence was obtained from
Ensembl genome browser (www.ensemble.org). Blast 2
sequences program (www.ncbi.nih.gov/blast/bl2seq/
bl2.html) was used to identify conserved non-coding
regions of the Hb9 gene between mouse and human.
Ensembl genome browser was also used to identify
evolutionarily conserved non-coding sequences of the Hb9
genes among mouse, rat, human, pufferfish, and zebrafish,
and then multiple sequence alignments were conducted
using MacVector (Accelrys).
Transgenic constructs
Construct #1 (3.6-kb Hb9 enhancer-b-globin-lacZ) was
generated by inserting a 3.6 kb NotI/Sse8387I fragment
derived from a 9-kb 5V non-coding fragment of the mouse
Hb9 gene into the NotI/PstI sites of the reporter construct
BGZA, which contains the b-globin minimal promoter,
lacZ gene, and SV40 polyadenylation cassette (a gift of
Dr. Jane Johnson). Construct #2 (5.4-kb Hb9 promoter-
lacZ) contains a 5.4-kb Sse8387I/PmeI fragment of the9-kb Hb9 promoter region into the PstI/SmaI sites of
placZpA. Construct #3 (438-bp Hb9 enhancer-b-globin-
lacZ) was obtained by cloning 313-bp and 125-bp
fragment derived from Constructs #4 and #5, respectively,
to BGZA.
Construct #4 (313-bp Hb9 enhancer-b-globin-lacZ): A
313-bp fragment was PCR amplified with the primers:
5V-ATAGCATAGCGGCCGCTGAATAAATTTAA-
GCAGGCT-3V, 5V-GCTCTAGAAGCCCCATCCCCC-
TTCAAT-3V,
and cloned into BGZA.
Construct #5 (125-bp Hb9 enhancer-b-globin-lacZ): A
125-bp fragment was PCR amplified with the primers:
5V-GACTAGTAGAGTGGTTAGCTGATGAAT-3V, 5V-
TCACCCGGGTCTAATCAGCCTGCCTAGCT-3V,
and cloned into BGZA. Constructs #4 and #5 contain three
copies of the 313-bp and 125-bp fragments, respectively, in
order to drive the reporter gene expression more efficiently.
Construct #6: The site-directed mutagenesis construct was
generated according to Ho’s method (Ho et al., 1989) using
the primers:
5V-ATAGCATAGCGGCCGCTGAATAATTTAAG-
CAGGCT-3V,
5V-TCGTTCGTTTTTGTCAACGCACGAGCTAACC-
ACTCTGGCTGGA-3V,
5V-TCGTGCGQTTGACAAAAACGAACGAGCTT-
CGAGCTTTATTGGGAAACAGGT-3V,
5V-TCACCCGGGTCTAATCAGCCTGCCTAGCT-3V.
All PCR-amplified fragments were verified by
sequencing.
Production and genotyping of transgenic mice
Transgenes for injection were separated from vector
sequences using 1% Seakim LE agarose (BMA), purified
on QIAquick gel extraction kit (Qiagen), precipitated in
injection buffer. Transgenic mice were generated by standard
procedures (Hogan et al., 1994) using fertilized eggs from
B6D2F1 9C57BL/6DBA) crosses. Transgenics were iden-
tified by PCR with the lacZ primers 5V-CGAGTGTGAT-
CATCTGGTCG-3V and 5V-TTACCTTGTGGAGCGA
CATC-3V using genomic DNA extracted from yolk sacs or
tails.
lacZ detection
b-gal staining of whole-mount embryos
Staged embryos were dissected from the uterus in cold
PBS and fixed for 45 min at 4-C in fixing solution (1%
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pH 7.4). Whole-mount b-gal staining was performed as
described (Ovitt et al., 1997).
b-gal staining of spinal cord tissue
To examine b-gal staining in adult spinal cord, stable
transgenic lines carrying Construct #1 (3.6-kb Hb9
enhancer-b-globin-lacZ) were established. Genotyped adult
transgenic mice were killed and perfusion fixed (1%
formaldehyde, 0.2% glutaraldehyde, 0.02% NP-40 in PBS
pH 7.4), and their spinal cords were removed. After b-gal
staining (Ovitt et al., 1997), post-fixation was performed in
the same fixative for 1–2 h at 4-C.
Immunohistochemistry
Embryos or adult spinal cords were cryosectioned at 15
Am, permeabilized with PBS, 0.1% saponin and 1% NGS,
and blocked with PBS, 0.05% saponin and 5% NGS, each
for 30 min. Sections were labeled with mouse anti-Islet1
(39.4D5, 1:100, DSHB), mouse anti-MNR2/Hb9 (5C10,
1:3, DSHB), or anti-ChAT (1:1000, Chemicon) overnight at
4-C. Species- and isotype-specific biotin-labeled secondary
antibodies were applied at 1:100 for 2 h at room temper-
ature. Staining was performed using the ABC kit (Vector)
and DAB (Sigma).
Protein production and electophoretic mobility shift assay
(EMSA)
PBX1 and HOX proteins used in this study were
produced in vitro from the corresponding pSG5-derived
expression vectors using a T7 polymerase-based coupled
transcription–translation reticulocyte lysate system (Prom-
ega, Madison, WI). EMSAwere performed according to the
instruction of the DIG gel shift kit (Roche). Briefly, 2 Al of
double-stranded DIG-labeled oligonucleotides was incu-
bated with 2 Al of in-vitro-translated proteins in 20 Al of
binding buffer [20 mM HEPES pH 7.6, 1 mM EDTA, 10
mM (NH4)2SO4, 1 mM DTT, 0.2% (w/v) Tween 20, 30 mM
KCl in the presence of 1 Ag of poly (dI–dC) and 0.1 Ag of
poly l-lysine) for 30 min at room temperature. Pre-binding
reactions of unlabeled competitor oligonucleotides at ¨100-
fold molar excess occurred for 15 min at room temperature.
The incubation mixture was resolved by electrophoresis and
served for chemiluminescent detection according to recom-
mended conditions of the DIG gel shift kit (Roche). DIG-
labeled DNA probes used were generated by annealing
complementary oligonucleotides:
Wild-type oligonucleotide probe (40 bp)
5V-GTACGTTAGCTGATGAATTGACAAAAACTAAT-
CAGCTTTA-3V
Mutant oligonucleotide probe (40 bp)
5 V-GTACGTTAGCTCGTGCGTTGACAAAAAC-
GAACGAGCTTTA-3VResults
Identification of a 3.6-kb MN enhancer within the Hb9 locus
Previous work identified a 9-kb 5V fragment of the
mouse Hb9 gene which is sufficient to direct spinal MN
expression in vivo (Arber et al., 1999; Wichterle et al.,
2002). To define the cis-acting regulatory sequences that
govern the expression of Hb9 by MNs, we first sought to
identify conserved regions between mouse and human
Hb9 genomic sequences. Such conservation across species
of non-coding sequences in the vicinity of a gene
frequently marks the presence of regulatory elements
(Muller et al., 2002). We thus compared the genomic
sequences of mouse and human 9 kb Hb9 promoter (see
Materials and methods). Five clusters of remarkably high
nucleotide sequence conservation (81% to 94%) were
found (Fig. 1A; conserved regions <70 bp not shown).
Three of these were located within a 5V 3.6-kb fragment,
whereas the other two were within the 5.4-kb Hb9
promoter region.
To identify which of these elements directed Hb9
expression, we established two transgenes, each of which
was placed in control of lacZ (Fig. 1B). Transgene #1,
containing the 3.6-kb Hb9 fragment, was tested for
enhancer activity by placing it 5V of the b-globin basal
promoter (P/b-globin) in a lacZ reporter vector, BGZA.
This vector contains lacZ placed under the control of
human P/b-globin, with an SV40 polyadenylation cassette;
in transgenics, it is inactive in the absence of an enhancer
(Helms et al., 2000; Yee and Rigby, 1993). We designated
the resultant plasmid E/Hb9 (3.6 kb):lacZ. For transgene
#2, the 5.4-kb Hb9 promoter was used intact, directly
driving lacZ with a polyA cassette, yielding the plasmid P/
Hb9 (5.4 kb):lacZ.
Using these constructs, we examined gene expression
patterns in transgenic embryos at 10.0–11.0 dpc. P/Hb9
(5.4 kb):lacZ (transgene #2), did not activate lacZ
expression in the neural tube (Fig. 1D). In contrast, E/
Hb9 (3.6 kb):lacZ (transgene #1) exhibited activity similar
to that of transgenic embryos with the entire 9-kb Hb9
promoter at E10.5–11.0 (Figs. 1C, 2A–C) (Arber et al.,
1999). These results were consistent in at least 4 embryos
bearing each transgene. In the E/Hb9 (3.6 kb) mice, lacZ
expression was noted in the ventral spinal cord at virtually
all cervical, thoracic, and lumbar levels. Transverse sections
revealed lacZ in the ventral horns and axons extending
from the areas (Fig. 2D), suggesting the motor neuron
specificity of E/Hb9 (3.6 kb) at E10.5–11.0. These lacZ+
cells co-expressed the MN transcription factors, Islet-1
(Fig. 2E) and Hb9 (Fig. 2F). Together, these results
indicated that, within the embryonic spinal cord, the 3.6-
kb promoter fragment of Hb9 specifically drives transgene
expression in motor neurons. At E11.5, b-gal was noted
within the trigeminal and facial motor nuclei as well as
olfactory epithelium (Fig. 2C), where endogenous HB9
Fig. 1. A 5V 3.6-kb fragment within the 9 kb Hb9 promoter regulates Hb9 gene expression. (A) Diagram of the Hb9 locus representing the Hb9 coding region
(open box) and highly conserved sequences between the human and mouse Hb9 loci (red boxes). The number and percentage of conserved nucleotides are
shown. Scale bar = 1 kb. The position of the two fragments (3.6 kb and 5.4 kb) used to analyze gene expression activity in the Hb9 region is indicated. (B)
Transgenic constructs used to study gene expression activity. Statistical overview of transgenic embryos is indicated. The transgenic embryos carrying construct
#1, but not #2, showed virtually the same spinal b-gal expression pattern with ones carrying MN-specific 9 kb Hb9 promoter. b-gl, b-globin basal promoter in
the BGZA reporter construct. (C, D) Representative pictures of E10.5 whole-mount stained embryos containing construct #1 (C) and #2 (D), respectively. OE,
olfactory epithelium; nV, trigeminal nerve; nVII, facial nerve; MNs, spinal motor neurons.
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some degree of ectopic expression by the 3.6-kb Hb9
enhancer at later time points.
The establishment of stable transgenic lines of E/Hb9
(3.6 kb):lacZ mice allowed us to examine gene expression
in the adult spinal cord as well. Several litters from each of
two independent transgenic lines were analyzed 8–12
weeks after birth. As in embryos, E/Hb9-driven lacZ was
restricted to magnocellular neurons that reside in the
median and lateral motor columns of the ventral spinal
cord (Figs. 3A, C). lacZ+ cells extended axons from
ventral horns (Fig. 3B) and co-expressed ChAT (Fig. 3D),
suggesting their MN phenotype. No differences were seen
between the two lines. Thus, the 3.6-kb Hb9 enhancer
continues to direct MN-specific gene expression in the
adult spinal cord.The 3.6-kb Hb9 enhancer harbors evolutionarily conserved
313-bp and 125-bp fragments
To identify cis-acting elements that might directly regulate
MN specification, we next used cross-species homology
screening to identify conserved elements within the 3.6-kb
Hb9 enhancer. Comparison of mouse, rat, human, pufferfish
(Fugu rubripes) 3.6-kb genomic sequences revealed two
blocks of high homology, of 313 bp (region A, red arrow) and
125 bp (region B, blue arrowhead) (Fig. 4A). We found that
both regions A and B were located within the 5V regulatory
region of the Hb9 genes, confirmed by perfect conservation
of the homeobox regions in these species (Fig. 4B). Overall,
regions A and B exhibited 74% and 82% homology between
mouse and Fugu, respectively (Figs. 4C–E). In Fugu, these
two conserved regions were located within the first 2 kb
Fig. 3. Expression patterns of reporter genes in the adult spinal cord. (A, B)
b-gal expressions in representative adult thoracic spinal cord of a 12-week
adult transgenic mouse carrying the construct #1. b-gal expressions were
located in the ventral horn. Arrow indicates extending axons. (C) A
transverse section of an adult spinal cord. The b-gal activity was restricted
to neurons with large cell bodies in the ventral side of spinal, suggesting
they are motor neurons. (D) ChAT immunoreactivity (arrowheads) co-
localized with b-gal.
Fig. 2. Transgene expression in whole-mount mouse embryos. (A–C) b-
galactosidase (b-gal) staining in E10 (A, B) and E11(C) E/Hb9
(3.6 kb):lacZ transgenic embryos. Lateral (A, C) and dorsal (B) views.
(D) A cross-section of E10.5 thoracic spinal cord showed b-gal expression
in the ventrolateral cord and spinal roots. (E–F) Coronal sections of E/Hb9
(3.6 kb):lacZ E10.5 spinal cord stained for Islet-1 (E) and Hb9 (F) proteins.
OE, olfactory epithelium; nV, trigeminal nerve; nVII, facial nerve; MNs,
spinal motor neurons. Scale bar = 100 Am.
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corresponding sequences in mouse and human were about
8 kb 5V of the Hb9 translation start site (Fig. 4A). This is
consistent with Fugu’s relatively compact genome. At
approximately 400 mb, it is nine times smaller than the
mouse or human genome, even though each of these genomes
has a similar number of genes (Aparicio et al., 2002; Brenner
et al., 1993).
We also analyzed Hb9 genomic sequence in the zebrafish
(Danio rerio), and found two copies of the identical region B
sequence within 2 kb of theHb9 translation start (Fig. 4A). In
contrast to Fugu, no region A sequence was found in the
zebrafish Hb9 locus, or for that matter anywhere else in the
whole zebrafish genome, suggesting that region Bmight play
a more important role than region A in Hb9 gene expression.
The 125-bp Hb9 enhancer directed motor neuron-selective
gene expression in transgenic mice
For functional analysis of the two conserved sequences A
and B, we generated several constructs whose relativeabilities to drive MN-specific reporter gene expression were
assessed in transgenics. Construct #3 included both putative
enhancers A and B. It is a 438-bp synthetic chimera that
consists of the otherwise noncontiguous 313-bp and 125-bp
fragments (Fig. 5A). Transgenic analysis showed that this
438-bp sequence was capable of appropriate temporal and
spatial activation of a reporter gene in the ventral spinal cord
(Figs. 5B–D). Other than slight lacZ expression in the facial
nerve, no other ectopic gene expression was noted with this
construct at E10.5–11.5. These observations indicate that
the Hb9 regulatory regions contained within the 438-bp
chimera of enhancers A and B are sufficient to direct MN-
specific gene expression.
Next, we generated constructs #4 and #5, containing
three copies of either the 313-bp (fragment A) or 125-bp
(fragment B) regions, respectively (Fig. 5A), to investigate
whether either of these fragments alone was sufficient to
direct MN-specific b-gal expression. Construct #4
expressed no b-gal at E10.5–11.5 (not shown). In contrast,
construct #5 expressed b-gal in the ventral spinal cord,
similar to the expression pattern of constructs #1 and #3 at
E10.5–11.5 (Figs. 5E–G). However, ectopic expression of
construct #5 was seen in several regions including the
ventral midbrain. Together, these results demonstrated that
the 125-bp element fragment B was sufficient to direct gene
expression to motor neurons, and as such, constituted the
Hb9 core enhancer. However, the 125-bp fragment yielded
some ectopic reporter expression as well, and required the
additional information supplied by the 313-bp element in
order to specify gene expression to MNs.
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enhancer activity
To identify potential transcription factor binding sites
within the 125-bp Hb9 enhancer, that might in turn suggest
upstream factors important for MN-specific Hb9 expression,
MATInspector (Quandt et al., 1995) was used to search theFig. 4. Identification of evolutionarily conserved genomic sequences among ve
positions and directions of the two highly homologous regions, namely, 313-bp reg
human, pufferfish, and zebrafish. B1 and B2 indicate two identical copies of the 1
acid sequences of the mouse Hb9 (MmHb9), rat Hb9 (RnHb9), human Hb9 (H
homeodomains. Perfectly conserved homeodomains among all listed species are
125-bp region B among evolutionary distinct species. (D, E) Alignment of the 313-
using the Clustral algorithm. The 125-bp region harbors two Hox/Pbx consensusTRANSFAC database (Heinemeyer et al., 1998). This
revealed two sequences (shaded in Fig. 4E), each highly
related to a bipartite Hox/Pbx (HP) consensus binding
sequence (TGATNNAT) (Chan and Mann, 1996; Di Rocco
et al., 1997) within the 125-bp sequence. These two binding
sequences were well conserved among mouse, human, rat,
pufferfish, and zebrafish (Fig. 4E). HOX proteins arertebrate Hb9 genes. (A) Schematic of Hb9 genomic region showing the
ion A (red arrow) and 125-bp region B (blue arrowhead), of the mouse, rat,
25-bp sequence found in zebrafish. (B) Comparison of the deduced amino
sHb9), Fugu Hb9 (FrHb9), zebrafish Hb9 (DrHb9) in the vicinity of the
shaded. (C) The degree of sequence identity of the 313-bp region A and
bp region A (D) and 125-bp region B (E) from mouse, rat, human, and Fugu
binding sequences (TGATNNAT).
Fig. 4. (continued).
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have been implicated as critical determinants of spinal MN
identity and organization (Dasen et al., 2003). Thus, it
seemed likely that the two conserved bipartite HP motifs
within the 125-bp Hb9 enhancer were involved in activation
of the Hb9 gene. To test this hypothesis, we generated
construct #6, by introducing mutations in two HP sites,
converting them from TGATNNAT to TCGTNCGT(Fig. 6A). We confirmed that HOX/PBX proteins failed to
form protein–DNA complexes with these mutated HPmotifs
(Fig. 6E), as previously reported (Maconochie et al., 1997).
Mutations of these sequences did not affect cervicalHb9 gene
expression, but completely disrupted more posterior MN-
specific gene expression. (Figs. 6B–D). Thus, the HP motifs
within the 125-bp Hb9 enhancer play a critical role in
directing MN gene expression in vivo.
Fig. 5. Functional characterization of the two evolutionarily conserved sequences. (A) Constructs and statistical overview of transgenic embryos. A, 313 bp
region A; B, 125 bp region B. (B–E) Expression patterns of reporter genes in representative transgenic embryos. (B–D) The expression of the b-gal is detected
in spinal MNs of transgenics staged between E11.0 (B) and E11.5 (C, D). (E–G) Staining was observed at the ventral side of spinal cord in the presence of the
evolutionarily conserved 125-bp fragments at E10.5 (E) and E11.5 (F, G), whereas the 313-bp fragments did not have any enhancer activity (data not shown).
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sites
Next, we tested a representative subset of HOX proteins
for cooperative DNA binding with Pbx1, to both the wild-
type and a mutated 40-bp sequence derived from the 125-
bp Hb9 enhancer (Fig. 6E). In the presence of PBX1, only
HOXB1 and HOXB3 proteins (Fig. 6D, lanes 2 and 3)
formed a detectable retarded complex with a DIG-labeled
wild-type oligonucleotide. No binding was detected with
PBX1 alone (lane 1), or with either of the HOX proteins
alone (not shown). Polyclonal antibodies against full-length
PBX1 protein completely abolished the formation of the
HoxB1 –Pbx1 complex (lane 6). In addition, the introduc-
tion of seven point mutations in the core HP motifsabolished cooperative Hox–Pbx complex formation (lane
8–11).Discussion
Evolutionary conservation of Hb9 regulatory elements
Homology searches between genomic sequences of
evolutionarily distant species offer a fast detection method
for gene regulatory sequences (Muller et al., 2002), and the
contracted genomes of the pufferfish and zebrafish have
successfully been used to identify conserved regulatory
elements in vertebrates (Aparicio et al., 1995). Using this
technique, we identified a 3.6-kb fragment first, and then
Fig. 6. Identification of a required element for Hb9 enhancer activity in the spinal cord. (A) Two Hox/Pbx binding motifs within 125 bp Hb9 enhancer, and the
introduced mutations in construct #6 are indicated. (B) The intact 125 bp Hb9 enhancer drove Hb9 expression in cervical, thoracic, and lumbar levels. (C) In
vivo inactivation of the 125-bp Hb9 enhancer by mutations of the two Hox/Pbx binding motifs. Expression in thoracolumbar MNs was not detected, whereas
cervical MN expression was not affected. (D) Low-power coronal section of panel C, taken through cervical cord. (E) EMSA of HOX and PBX1 binding to a
40-bp wild-type or mutant oligonucleotide derived from 125 bp Hb9 enhancer. Two Hox/Pbx binding motifs are shown in bold. (Top) Two different
oligonucleotides, proteins and antibodies used for binding reactions are indicated. Hox/Pbx indicates the slower migrating complex formed on the wild-type
oligonucleotide. FP = free probe. NS = non-specific complexes.
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313-bp (region A) and 125-bp (region B) fragments within
the 9-kb mouse Hb9 promoter. Transgenic analysis showed
that when these two fragments were serially combined, the
resultant 438-bp sequence directed an appropriate temporal
and spatial pattern of reporter gene expression in spinal
MNs. Further transgenic analysis then showed that the 125-
bp region B directed MN-selective expression in vivo, and
that the 313 segment was incapable of independently
driving reporter gene expression. In this regard, we notedthat the zebrafish genome does not contain sequences
homologous to the 313-bp region A; rather, BLAST search
detected two identical copies of the region B sequence,
designated B1 and B2. Together, these data indicate that this
125-bp element represents a motor neuron-specifying Hb9
core enhancer.
b-gal expression under the control of this enhancer
largely coincided with endogenous Hb9 expression, but
there were a few differences. These included a lack of b-gal
expression in the most caudal segment of spinal cord, and
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endogenous Hb9 expression (Thaler et al., 1999). Given the
difficulty of detecting small fragments of conserved
sequences by blast search, especially less than 80 bp, it is
possible that there are other functional sequences – both
enhancers and silencers – within the 9-kb Hb9 promoter. In
this regard, Lee et al. have recently identified a 246-bp MN
enhancer, located from 7135 bp to 6890 bp upstream of
the Hb9 gene (Lee and Pfaff, 2003; Lee et al., 2004), based
on its high genomic sequence conservation between human
and mouse (>90%). This 246-bp sequence does not overlap
with our evolutionarily conserved 125 bp, which is situated
7917 bp to 7793 bp upstream of the Hb9 coding region.
In addition, the 246-bp MN enhancer is not conserved
across phylogeny; extensive blast searches failed to identify
highly homologous sequences in either the Fugu or zebra-
fish Hb9 genomic loci. In contrast, the percent identity of
our 125-bp Hb9 enhancer sequence among evolutionarily
distinct species, including Fugu and zebrafish, exceeded
82%. Together, these studies suggest the existence in
mammals of two distinct and non-overlapping MN
enhancers, of 125 and 246 bp. Though the 125-bp enhancer
is the more phylogenetically conserved, both appear
sufficient to direct gene expression to mammalian motor
neurons.
Previous studies identified a 4.4-kb Ngn2 enhancer that
exhibited a similar pattern of spinal gene expression as the
125-bp Hb9 enhancer (Simmons et al., 2001). However,
blast search between Hb9 and Ngn2 enhancers detected no
significant similar sequences, suggesting that the respective
expression patterns of these genes are regulated by different
upstream transcription factors. Moreover, we conducted
blast searches to identify other MN-selective genes that
included Islet1 and ChAT, whose regulatory regions might
share homology with the Hb9 125-bp enhancer. No such
blast hit was detected, indicating that the 125-bp enhancer
might be regulated uniquely. Unlike the 125-bp region B,
the 313-bp region A had no independent enhancer activity.
Consistent with this, the zebrafish genome lacks homology
to the 313-bp region A. The role of the 313-bp sequence is
not clear, but it might function as a silencer that suppresses
gene expression in cells other than MNs. Accordingly, we
noted that the 125-bp Hb9 enhancer-driven lacZ transgenics
exhibited increased ectopic b-gal expression, compared to
the more specific expression directed by the 438-bp
chimeric enhancer, which contained the 313-bp region B
sequence.
The 3.6-kb Hb9 enhancer directs MN-specific gene
expression in the adult spinal cord
Both Hb9 and Islet-1 are expressed in adult as well as
developing MNs (Vult von Steyern et al., 1999). We thus
tested whether our identified Hb9 enhancer was capable of
driving Hb9 expression in adult MNs. We examined the 3.6-
kb Hb9 enhancer for this purpose, because it confers strongb-gal expression in MNs, more so than that afforded by the
438-bp enhancer, and did so without the ectopic expression
noted using the 125-bp enhancer alone. In addition, the 3.6-
kb segment includes both our 125-bp enhancer and Lee et
al.’s 246-bp enhancer. Accordingly, we found that b-gal
expression in the adult E/Hb9(3.6kb):lacZ spinal cord was
restricted to magnocellular neurons of the ventral horns,
confirming that the 3.6-kb Hb9 enhancer can target adult
MNs. As such, this enhancer may prove useful in establish-
ing MN-targeted vectors, as a means of specifically
delivering therapeutic transgenes to vulnerable cells in the
motor neuron diseases, such as spinal muscular atrophy and
amyotrophic lateral sclerosis. For example, since lentivirus
vectors have roughly 8 kb in cloning capacity, the identified
3.6-kb enhancer may be useful to specifically target
therapeutic genes of interest (e.g., GDNF, erythropoietin,
and/or Bcl-2) to MNs, as a means of selectively supporting
those cells and no other. Alternatively, the 3.6-kb Hb9
enhancer can be used as a MN selection vector, for instance,
via fluorescence-activated cell sorting (FACS), using GFP
as a reporter (Roy et al., 2004).
A role of Hox/Pbx binding sequences in regulating Hb9
expression
Lee and Pfaff reported that Ngn2/NeuroM transcription-
ally synergize with Islet-1 and Lhx3 to directly bind the
250-bp Hb9 enhancer, thereby activating Hb9 expression
(28). However, most reported regulators of Hb9 expression,
such as Nkx6.1 and Olig2, are transcriptional repressors that
do not appear to directly drive Hb9 expression. Our
conserved 125-bp Hb9 enhancer does not contain E-box
sites, suggesting that it may not be regulated by Ngn2/
NeuroM. Rather, we posited that the 125-bp Hb9 enhancer
might direct MN-selective gene expression following bind-
ing by other transcription factors, yet-to-be identified.
To better define these alternative molecular pathways of
MN induction, we first performed TF binding site analysis
of the 125-bp Hb9 enhancer. This revealed two potential
Hox/Pbx (HP) binding sequences (Fig. 4E) within the 125-
bp Hb9 enhancer, that were also evolutionarily conserved.
Along the A–P axis, the nested expression pattern of HOX
homeodomain proteins provides positional values that
influence the fate of neurons (Lumsden and Krumlauf,
1996), including MNs (Liu et al., 2001; Tiret et al., 1998).
Moreover, in the developing hindbrain, misexpression of
Hoxa2 or Hoxb1 leads to the generation of ectopic MNs
(Jungbluth et al., 1999). Our mutagenesis study showed that
Hox/Pbx binding sites were essential for Hb9 expression in
thoracolumbar MNs, suggesting that Hox/Pbx could be a
critical upstream regulator of Hb9 in these cells. In addition,
gel retardation analysis showed that HOXB1 and HOXB3
bound to wild-type sequence derived from the 125-bp Hb9
enhancer in the presence of PBX1 in vitro, whereas HOXC8
or HOXD9 did not form the retarded complex. These results
suggested that HoxB genes may play an important role in
T. Nakano et al. / Developmental Biology 283 (2005) 474–485484regulating Hb9 expression. Interestingly, HoxB1, but not
HoxB3, HoxC6, or HoxD9, has previously been shown to
bind b1-ARE in vitro, and to regulate HoxB1 expression (Di
Rocco et al., 1997). Yet, HOXB3 bound the 125-bp Hb9
sequence more avidly than did HOXB1. HOXB1 is
expressed strongly in the hindbrain where Hb9 is not
expressed, and its spinal cord expression terminates at about
E9.5. Thus, HOXB1 might play a role in the initiation of
Hb9 expression, but not in its maintenance after E9.5. On
the other hand, HOXB3 appears to be co-expressed with
Hb9 throughout most of its expression domain in the
developing spinal cord, though its expression extends more
rostrally than that of Hb9, suggesting HOXB3 might play
the more important role in Hb9 expression.
Interestingly, TF binding analysis also revealed that one
of the two Hox/Pbx binding sequences contains an over-
lapping binding sequence of bicoid-class homeoprotein
(TAATC). However, since none of the known bicoid-class
homeoproteins including Otx, Goosecoid (Gsc), and Pitx,
are expressed in the developing spinal cord (Gage et al.,
1999; Gaunt et al., 1993; Simeone et al., 1993), it seems
unlikely that bicoid binding influences MN gene expres-
sion, barring the identification of other competent bicoid-
class homeoproteins with spinal cord expression.
Taken together, these results suggest that the evolutio-
narily conserved 125-bp region B is a core enhancer that
directs gene expression to motor neurons; as such, the
molecular pathways regulatingHb9 expression would appear
to be highly conserved across phylogeny. Our data also
specifically suggest that HOX/PBX proteins are necessary for
the expression of Hb9 by thoracolumbar MNs, and as such,
play a critical role in the segmental specification of spinal
MNs. Thus, dorsoventral patterning of the thoracolumbar
spinal cord, and Shh-dependent MN specification in partic-
ular, would appear to be coordinated with the rostrocaudal
patterning of MNs, through HOX/PBX proteins. Besides the
developmental insights brought to bear by the identification
and analysis of the 125-bp Hb9 core enhancer, this sequence
as well as the 3.6-kb may have great practical and transla-
tional value: MN-specifying elements such as the Hb9 core
enhancers may permit us to create not only MN-specific
selection vectors, as noted (Roy et al., 2004), but also MN-
targeted plasmid and viral vectors for gene therapy. These in
turn may permit systemic and whole-CNS administration of
gene therapeutics, that may be specifically targeted to spinal
MNs using the Hb9 enhancer.Acknowledgments
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